Filter
324
Filtered Results: 324
Text search:
farmacéutica
Featured
Recommendations
25
New Publications
50
Language
Document type
Guidelines
120
No document type
97
Studies & Reports
36
Manuals
29
Strategic & Response Plan
25
Fact sheets
7
Training Material
3
Situation Updates
3
Resource Platforms
2
Brochures
1
Infographics
1
Countries / Regions
Latin America and the Carribbean
35
Brazil
27
Venezuela
20
Argentina
20
Colombia
19
Paraguay
19
Peru
18
Chile
16
Mozambique
14
Global
11
Bolivia
10
Ecuador
10
Spain
6
Western and Central Europe
5
Angola
5
El Salvador
4
Guinea-Bissau
4
Eastern Europe
3
Mexico
2
Ghana
2
Africa
2
Eastern Europe and Central Asia
2
Uruguay
2
Nicaragua
2
Honduras
2
Guatemala
2
Dominican Republic
1
Portugal
1
Russia
1
Eswatini/ Swaziland
1
Cuba
1
Authors & Publishers
Publication Years
Category
COVID-19
66
Guidelines
64
Drugs & Medical Equipment
24
Policies & Guidelines HIV & TB
22
Studies & Reports
22
Policies
17
Pharmaceutical Assessments
10
Humanitarian Crisis
7
Statistics
7
Women & Child Health
6
Humanitarian Aid
4
Cardiovascular Diseases
4
Non-communicable Diseases
4
Reproductive Health
4
TB
4
Family Planning
3
Pediatrics
3
Chagas
3
Yellow Fever
3
Information, Education and Communication (IEC)
3
Palliative Care
3
HIV & STI
3
Paediatrics
2
Hepatitis
2
Vaccine-preventable Diseases
2
Community Health
2
Capacity Building
2
Immunization
2
General Guidelines
2
Gynaecology & Obstetrics
2
Dental & Eye Care
1
Emergency Health Kits
1
Under-5 nutrition
1
Child Health
1
Diabetes
1
Disaster Preparedness
1
Laboratory Waste
1
x MEDBOX Issue Brief & Annual Reports x
1
Palliative Care
1
Pediatric cancer
1
Infection Control & Prevention (IPC)
1
Countries
1
NCD
1
Mental Health
1
Other
1
Waste Management
1
Needs Assessment
1
Nutrition
1
Primary Health Care
1
Age & Elderly
1
Neonatal Care
1
Malaria
1
Food Security & Nutrition
1
Toolboxes
Country specific documents
55
Children/Adolescents Mental Disorders
9
Pharmaceutical Assessments
9
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
8
International
8
Country specific
6
Prevention & Control
5
Clinical Guidelines
5
Infection Control General
5
Oxygen Therapy
5
Essential Medicines & Devices Lists
5
Pharmacy Practice
5
Rational use of Medicine
5
Pharmacovigilance
5
Detection & Diagnosis
5
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
5
Agriculture & Veterinary
4
Faith-based Organizations
4
Fair Allocation & Ethical Aspects
4
Supply Chain & Store Management
4
Argentina
4
Moldova
3
General Studies & Reports
3
Infection Prevention & Hygiene
3
COVID-19
3
Encyclical Letters
3
Essential Medicines & Medical Devices
3
Communication Material
3
Moderna
3
Biontech/Pfizer Comirnaty
3
Inactivated COVID-19 Vaccines
3
Overview
3
Peru
3
Assessment & Response
3
ART Drug Resistance
2
Childhood TB
2
Yellow Fever Prevention & Control
2
Substance Use Disorders, Others
2
Policies
2
Strategies & Action Plans
2
Latin America
2
Supporting tools
2
General
2
Diagnostics & Laboratory Guidance
2
Surveillance & Contact tracing
2
Global Impact: Socio-economic, health services, TB & HIV
2
Social Ethics
2
RCCE Guides & Manuals
2
Tips & Best Practice Examples
2
Immunization Guidelines
2
Logistics & Supply
2
Brazil
2
Falsified & Substandard
2
Women & Maternal Health
2
Epilepsy
2
Strategies & Roadmaps
2
Prevention & Strategies
2
Drug resistant TB
2
Substance Use Disorders & Addiction
2
Latin America & the Carribean
2
Reports & Studies
2
Risk Communication & Community Engagement
2
Drugs
1
Alcohol
1
TB & Drug Abuse
1
Influenza Prevention & Control
1
Adults
1
Mental Health
1
Clinical Guidelines
1
Laboratory
1
IEC Materials
1
TB & Other Vulnerable Populations
1
Children
1
Health & Refugee
1
Attention deficit hyperactivity disorder (ADHD)
1
Epilepsy
1
General
1
Prevention & Preparedness
1
Essential List
1
PPE Personel Protective Equipment
1
For Parents & Children
1
Clinical Guidelines
1
Country Specific
1
Appeals and Response Plans
1
Child Protection
1
Information for the Public
1
Country-specific Platforms
1
Educational Settings
1
Physical Distancing
1
Mythbusters/Misinformation
1
Vaccination & Strategy
1
SARS-CoV-2 Variants
1
Vaccine Hesitancy & Myths
1
Vector-based Vacines General
1
Covaxin
1
Research & Pipeline
1
Waste Management
1
Advocacy & Communication
1
Colombia
1
El Salvador
1
Other Countries
1
Ecuador
1
Planetary Health
1
Clean air
1
Pharmacy Management
1
Traditional & Herbal Medicines
1
General documents One Health
1
General Guidelines for Rational Use
1
Waste Managment
1
Reports & Studies
1
Mental Disorders
1
Health Care Systems
1
Health Impact & Climate Change
1
Information & Education Material (IEC)
1
Studies & Reports
1
Studies & Reports
1
Prevention & Control
1
Patient Safety
1
Studies & Reports
1
Prevention & Strategies
1
others
1
Disease Prevention & Control
1
Training
1
Research & Access
1
Stewardship
1
Situation Reports
1
Assessment
1
Zika Prevention & Control
1
Tobacco
1
Community Based Rehabilitation (CBR)
1
HIV in Key Populations
1
Global Health Action
1
Trastornos externalizantes
Capítulo D.1.1
Edición: Matías Irarrázaval & Andres Martin
Traductores: Fernanda Prieto-Tagle & Carlos Gómez
The Access to Controlled Medications Programme identified the development of treatment guidelines that cover the treatment of all types of pain as one of the core areas of focus for improving access to opioid analgesics. Such guidelines are interesting both for health-care professionals and policy-...
La presente publicación describe la evidencia científica publicada respecto a la hipertensión como factor pronóstico en pacientes con COVID-19. Se identificó una revisión sistemática que evaluó diferentes desenlaces de pronóstico en pacientes con hipertensión y diagnóstico confirmado de C...
La presente publicación describe un resumen de la evidencia científica disponible sobre el uso de Cloroquina e hidroxicloroquina, así como su profilaxis y tratamiento para COVID-19.
Esta publicación pertenece al compendio Publicaciones Minsa sobre COVID-19
La presente publicación describe la evidencia científica disponible sobre la efectividad del uso de mascarillas o respiradores en la prevención y control de infecciones respiratorias virales incluido COVID-19 a nivel comunitario y hospitalario. Se identificaron 778 estudios publicados hasta abril...
La presente publicación describe la evidencia científica disponible sobre la precisión diagnóstica de las pruebas rápidas de detección de antígenos para SARS-COV-2. El conocimiento de las pruebas diagnósticas para el coronavirus del síndrome respiratorio agudo grave 2 (SARS-COV-2) sigue evo...
El presente documento compila cronológicamente la normatividad legal-administrativa de salud, del diario oficial El Peruano y normas internas de la institución, de acuerdo al tema de COVID-19, correspondiente al segundo semestre 2020.
Lista Nacional de Medicamentos Esenciales
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate...
Chronic respiratory diseases, such as asthma and
chronic obstructive pulmonary disease, kill more than
four million people every year and affect hundreds
of millions more. These diseases erode the health
and well-being of the patients and have a negative
impact on families and societies. Women ...
Chronic respiratory diseases, such as asthma and
chronic obstructive pulmonary disease, kill more than
four million people every year and affect hundreds
of millions more. These diseases erode the health
and well-being of the patients and have a negative
impact on families and societies. Women ...
Organización Mundial de la Salud. (2022). Recomendaciones provisionales sobre el uso de la vacuna CanSinoBIO Ad5-nCoV-S [recombinante] (Convidecia™) contra la COVID-19: orientaciones provisionales, primera publicación: 19 de mayo de 2022.
Este manual pretende estandarizar la práctica del SFT para que el QF pueda trabajar
con los usuarios de forma consistente y estandarizada a nivel nacional.
Los datos preliminares de eficacia se infirieron mediante un enfoque de “inmunogenicidad puente”, en el que los títulos neutralizantes obtenidos después de la vacuna en niños y niñas de 5 a 11 años se compararon con los títulos obtenidos en adolescentes de 16 a 25 años (en quienes se hab...
